Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Epigallocatechin Gallate and Uridine Triacetate

Research Papers that Mention the Interaction

Discussion: In this study, we show that EGCG enhances the clearance of AD-relevant phosphorylated tau species in primary neurons.
Taken together, these results demonstrate that EGCG has the ability to increase the clearance of phosphorylated tau species in a highly specific manner, likely through increasing adaptor protein expression.
This study assessed whether EGCG could also alter tau clearance.
Nutritional neuroscience  •  2016  |  View Paper
We show that (−)‐epigallocatechin gallate (EGCG), a green tea polyphenol that was previously found to reduce Aβ aggregation, inhibits the aggregation of tau K18ΔK280 into toxic oligomers at ten‐ to hundred‐fold substoichiometric concentrations, thereby rescuing toxicity in neuronal model cells.
FEBS letters  •  2015  |  View Paper
In … how EGCG can … prevent Tau aggregation: (i) in binding Tau in its phosphorylation region with an affinity of the same order of magnitude than kinases (0.5 … to the protein and (ii) in modifying the 3D-structure of Tau whose preferential conformation changes in the presence of EGCG.
The journal of prevention of Alzheimer's disease  •  2017  |  View Paper
EGCG treatment also prevented the hyperphosphorylation of tau and reversed the decreased synaptic protein marker synaptophysin and postsynaptic density protein 95 in FC and Hip of SAMP8 mice.
Neuroreport  •  2017  |  View Paper
EGCG potently inhibited MG-induced advanced glycation endproducts formation in neuroblastoma cells as well modulated the localization of AT100 phosphorylated Tau in the cells.
Oncotarget  •  2021  |  View Paper
EGCG decreased the hyperphosphorylation of Tau in hippocampus.
Drug design, development and therapy  •  2021  |  View Paper